Rivastigmine Tartrate
- Product NDC
- 60687-574
- 11-digit product format
- 606870574
- Labeler code
- 60687
- Product ID
- 60687-574_eb6b0851-c4d1-363e-e053-2a95a90a5134
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rivastigmine Tartrate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA091689
- Marketing category
- ANDA
- Marketing start
- 2020-08-19
- Marketing end
- 2024-07-31
- Substance
- RIVASTIGMINE TARTRATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60687-574-01 | 60687057401 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-574-01) > 1 CAPSULE in 1 BLISTER PACK (60687-574-11) | 100 blister pack | 2020-08-05 | 0000-00-00 | No | No | Current |